Monash scientists debug superbug

March 02, 2009

An international team of scientists, led by Monash University researchers, has uncovered the workings of a superbug that kills elderly hospital patients worldwide - a discovery that has the potential to save lives and health care systems billions of dollars each year.

The research published today in the prestigious scientific journal Nature, unravelled ways to genetically modify the bacterium Clostridium difficile and solved the mystery surrounding its toxicity.

Professor Julian Rood from the Department of Microbiology and lead author, microbiologist Dr Dena Lyras, made a major scientific breakthrough which allowed mutants of the superbug to be made. They then identified which of two suspected toxic proteins was essential for the bacterium to cause severe disease.

"Contrary to previously accepted scientific belief, our results show that toxin B, which was considered the less important toxin is actually the toxin that causes disease," Professor Rood said.

"This discovery will lead to new methods for the control and prevention of this disease".

Professor Rood and Dr Lyras have been working toward this result for more than a decade. Dr Lyras said strains of Clostridium difficile are found in almost every hospital in Australia.

"It is the major cause of diarrhoea in hospital patients undergoing antibiotic therapy. The antibiotics destroy the 'good' bacteria in the gut, allowing a 'bad' bacterium to grow in the colon, where it causes a chronic bowel infection that is very difficult to treat," Dr Lyras said.

"The disease produces two types of Toxins, known as A and B. Worldwide research has tended to focus on these purified toxins in isolation from the bug. This only resulted in part of the story being told. We took a big picture approach and through genetic modification of the bug, together with infection studies with our US collaborators, we were able to see the whole picture," Dr Lyras said.

Statistics show that in the US, more people die from Clostridium difficile infections than all other intestinal infections combined, with most deaths involving patients aged 65 years or over. The disease is believed to have contributed to more than 8,000 deaths in the UK in 2007. A less aggressive form of the bacteria is present in Australia but statistics in 1995-dollars show the cost of managing the disease to be around $1.25 million dollars per hospital, per year.

Their research lays the foundation to find better ways to treat the superbug.

"We are now beginning to understand the workings of the superbug, which allows us to work on treatments for it. We are confident our research will pave the way for future drugs to try to wipe out this disease. I can't put a time frame on how quickly drugs could be developed, but we're certainly on that road to discovery," Dr Lyras said.

Monash University

---

---

	Superbug: The Fatal Menace of MRSA by Maryn McKenna (Author) LURKING in our homes, hospitals, schools, and farms is a terrifying pathogen that is evolving faster than the medical community can track it or drug developers can create antibiotics to quell it. That pathogen is MRSA—methicillin-resistant Staphyloccocus aureus—and Superbug is the first book to tell the story of its shocking spread and the alarming danger it poses to us all. Doctors long thought that MRSA was confined to hospitals and clinics, infecting almost exclusively those who were either already ill or old. But through remarkable reporting, including hundreds of interviews with the leading researchers and doctors tracking the deadly bacterium, acclaimed science journalist Maryn McKenna reveals the hidden history of MRSA’s relentless advance—how it has overwhelmed hospitals,...
	Beating Back the Devil by Maryn McKenna (Author) IN THE WAR AGAINST DISEASES, THEY ARE THE SPECIAL FORCES. They always keep a bag packed. They seldom have more than twenty-four hours' notice before they are dispatched. The phone calls that tell them to head to the airport, sometimes in the middle of the night, may give them no more information than the country they are traveling to and the epidemic they will tackle when they get there. The universal human instinct is to run from an outbreak of disease. These doctors run toward it. They are the disease detective corps of the U.S. Centers for Disease Control and Prevention (CDC), the federal agency that tracks and tries to prevent disease outbreaks and bioterrorist attacks around the world. They are formally called the Epidemic Intelligence Service (EIS) -- a group founded more...
	Viruses vs. Superbugs: A Solution to the Antibiotics Crisis? by Thomas Häusler (Author) In the US alone some 90,000 people die from superbugs--bacteria that have grown immune to antibiotics. Officials agree that this problem will only get worse with time and new alternatives must be found. One alternative that is being considered by scientists is a kind of virus called a bacteriophage. "Phages"--viruses that kill bacteria but not humans--were discovered in 1915. Phage therapy was successfully used for twenty years before the invention of penicillin made them obsolete everywhere but Eastern Europe, where they are still in use today. In its first English translation, this book tells the fascinating story behind the history of the phage, its discovery and development, as well as the strides that are being made to bring the therapy back to the West today.
	Superbugs Strike Back: When Antibiotics Fail (Discovery!) by Connie Goldsmith (Author)
	Resistant 'superbugs' create need for novel antibiotics.(Reprint): An article from: Dermatology Nursing by Teri Capriotti (Author) This digital document is an article from Dermatology Nursing, published by Thomson Gale on February 1, 2007. The length of the article is 4367 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Resistant 'superbugs' create need for novel antibiotics.(Reprint) Author: Teri Capriotti Publication: Dermatology Nursing (Magazine/Journal) Date: February 1, 2007 Publisher: Thomson Gale Volume: 19 Issue: 1 Page: 65(6) Article Type: Reprint Distributed by Thomson...
	Superbugs (Hot Topics) by John DiConsiglio (Author) Superbugs, bacterial infections and diseases that have become immune to current antibiotics, are more common. What makes a superbug and why are they becoming more frequent? Is there anything we can do to protect ourselves from superbugs? This book answers these questions and more.
	Superbugs: The Rise of Drug-Resistant Germs (In the News) by Stephanie Watson (Author)
	Probiotic Rescue: How You can use Probiotics to Fight Cholesterol, Cancer, Superbugs, Digestive Complaints and More by Allison Tannis (Author) "Probiotic Rescue is your road map to the safe and effective use of probiotic supplements for health and disease prevention." —Donald J. Brown, N.D.Probiotics will improve your health!It has long been understood that probiotics can help calm and heal nearly any digestive complaint, including bloating and indigestion, irritable bowel syndrome, celiac disease and more. But did you know that the most cutting-edge research shows probiotics can help to prevent or treat cancer, improve your skin, and avoid osteoporosis and heart disease? With health benefits for people of every age, probiotics are the most important nutritional breakthrough of the century. In this outstanding, comprehensive resource, you will find:chapter-by-chapter, scientifically supported disease treatments and...
	Superbugs and Superdrugs: A History of MRSA ([Wellcome Witnesses to Twentieth Century Medicine]) by L A REYNOLDS (Editor), E M TANSEY (Editor) Because of its unique adaptability and resistance to many antibacterial drugs and antiseptics, methicillin-resistant Staphylococcus aureus (MRSA) is a nosocomial menace of the present day. It has invaded medical and surgical wards in hospitals, infecting patients already ill or recovering, and endangering clean surgical operations, encouraged by overcrowding and limited air circulation. It has now spread from hospitals to families and communities. Infection control microbiologists and the Public Health Laboratory Service developed assays, 'phage typing and other tests to identify strains, with better understanding of their behaviour aided by the discovery of the mecA gene. This Seminar addressed the biological reasons for this behaviour; the difference between resistant and non-resistant...
	Investigating Tuberculosis and Superbugs: Real Facts for Real Lives (Investigating Diseases) by Evelyn B. Kelly (Author), Ian Wilker (Author), Marylou Ambrose (Author)